Investors

Date	Name	Title	Type	Shares Traded	Price Range
Jul 27, 2011	goldberg murray a	Officer	Automatic Sell	12,258	53.18
Jul 28, 2011	goldberg murray a	Officer	Automatic Sell	9,705	52.76 - 56.24
Aug 1, 2011	powchik peter	Officer	Option Execute	15,144	15.64
Aug 4, 2011	van plew daniel p	Officer	Option Execute	4,784	20.90
Aug 10, 2011	baker charles a	Director	Option Execute	4,000	28.81
Aug 15, 2011	goldberg murray a	Officer	Option Execute	15,000	11.64
Aug 15, 2011	goldberg murray a	Officer	Automatic Sell	8,591	56.61
Aug 16, 2011	goldberg murray a	Officer	Automatic Sell	6,409	56.46 - 57.26
Aug 31, 2011	vagelos p roy	Officer	Option Execute	312,500	28.01
Aug 31, 2011	vagelos p roy	Officer	Automatic Sell	220,045	60.96
Sep 1, 2011	larosa joseph j	Officer	Acquisition (Non Open Market)	10,000	n/a
Sep 1, 2011	vagelos p roy	Officer	Automatic Sell	3,500	60.00
Sep 2, 2011	aberman michael s	Officer	Option Execute	4,166	24.00
Sep 2, 2011	aberman michael s	Officer	Automatic Sell	4,166	64.00
Sep 2, 2011	vagelos p roy	Officer	Automatic Sell	88,955	60.35 - 62.04
Sep 6, 2011	aberman michael s	Officer	Option Execute	8,334	24.00
Sep 6, 2011	aberman michael s	Officer	Automatic Sell	4,957	65.76
Sep 6, 2011	goldberg murray a	Officer	Option Execute	32,879	11.64 - 19.43
Sep 6, 2011	goldberg murray a	Officer	Automatic Sell	19,348	65.76
Sep 6, 2011	roberts william	Officer	Option Execute	30,000	11.64
Showing 301-320 of 639 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.